Non-Invasive Serum and Elastography-Based Markers of Fibrosis Staging in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review. AGDD. 2024;7(1):32-6. doi:10.5281/zenodo.22179529